Thor Equities Group has signed a new deal at its life sciences building in Jersey City, leasing nearly 30,000 square feet of lab-ready space to a nonprofit biotechnology organization.
New Jersey needs turnkey lab space, faster approvals to compete for life sciences users
Experts say New Jersey faces a growing challenge: While it’s still a major draw for pharmaceutical research and development, speed to market has become increasingly important to life sciences users. That means the state’s lack of move-in-ready lab space — and its lengthy approval process for new construction — puts it at a disadvantage to competing markets.
